About
A senior-led alternative to large consulting firms and their handoff structures. The advisor who scopes your engagement does the work, start to finish.
Domain expertise
We specialize in Life Sciences R&D: pharmacovigilance, clinical systems, regulatory submissions, and GxP validation. Direct operational experience combined with AI fluency, built from years inside the work, not consulting about it.
Leadership
Founder & Principal
A career spanning life sciences R&D and technology transformation. Arvind founded Altio Advisory to provide focused, senior advisory in an industry that has been over-served by junior generalists.
Expertise: pharmacovigilance operations, clinical platforms, regulatory technology, and AI-enabled operating-model design at global pharma scale.
AI Architect & Researcher
Specializes in machine learning, generative AI, and analytics-platform design, with prior roles at Sanofi and CSL building architectures for scientific use cases.
Expertise: AI/ML system architecture for regulated environments; founded the AI and quantum-computing research program at the University of Maryland.
Senior Medical Advisor
Physician leader with over 17 years in the pharmaceutical industry, most recently Vice President in AbbVie's Pharmacovigilance and Patient Safety organization, leading the teams responsible for safety across the full AbbVie portfolio. Previously faculty and Co-Director of the Evidence-based Practice Center at Duke University Medical Center, she brings clinical medicine and evidence-based decision science to drug safety, including one of the industry's early pilots of AI in signal management.
Expertise: clinical trial safety planning and monitoring; signal management and benefit-risk evaluation; global health-authority submissions; evidence-based medicine, with 40+ peer-reviewed publications.
Why boutique matters
A single senior perspective spans the regulatory, technical, and operating model, with no specialist relay race.
A deliberately limited client roster means your engagement gets the senior attention it actually needs.
Years inside Life Sciences R&D, not just observing it. The advice is grounded in having done the work.